NATCO completes acquisition of Dash Pharmaceuticals LLC01 January 2022

Saturday January 1, 2022 at 6:24 pm

Dash is a front-end pharmaceutical sales, marketing and distribution entity in the USA which is expected to have Net Sales of approximately USD 15 million for the financial year ending December 2021.

This acquisition provides NATCO with a platform to engage with its customers directly in the USA which is the largest pharmaceutical market in the world

Releted Blog